HTA capacity-building + Dx reimbursement gaps barrier
Key Questions
What are the main gaps in HTA capacity in LMICs and MENA?
Low- and middle-income countries (LMICs) and MENA regions face significant health technology assessment (HTA) gaps, limiting access to diagnostics and treatments. Donor technical assistance and roadmaps are recommended to build capacity.
How do reimbursement gaps affect diagnostics?
Payer silos, bundled payments, and value-based care (VBC) create reimbursement barriers for diagnostics, as seen in UCSF and Michigan contracts. Advocacy and real-world evidence (RWE) are key to addressing these.
What initiatives promote global HTA capacity-building?
Magnolia hosts RWE and global HTA webinars; Malama ties with insurers support reimbursement. UCSF and WEF reinforce donor TA, roadmaps, and Dx advocacy for better access.
LMICs/MENA gaps; UCSF payer silos/bundled/VBC (Michigan contracts); Malama insurer ties; Magnolia RWE/global HTA webinars. Donor TA/roadmaps; Dx advocacy; WEF reinforces.